BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
5.67
+0.07 (1.25%)
At close: Oct 8, 2025, 4:00 PM EDT
5.74
+0.07 (1.23%)
After-hours: Oct 8, 2025, 7:07 PM EDT
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $203.27 million as of October 8, 2025.
Market Cap
203.27M
Enterprise Value
-102.10M
1-Year Change
n/a
Ranking
Category
Stock Price
$5.67
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $203.27M, a decrease of -66.95%. That is a compound annual growth rate of -65.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 200.76M | -3.28% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 760.20B |
| Johnson & Johnson | 451.88B |
| AbbVie | 405.58B |
| UnitedHealth Group | 326.02B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 232.51B |